| Revenue growth | -3.13% YoY for FY26. |
|---|---|
| Margins | EBITDA margin improved slightly to 13.8% in FY26. |
Growth
FY26 revenue down 3%; EBITDA down 2% to ₹374 Cr. PAT up 5% due to margin expansion to 6.6%.
Outlook
Capex of ₹139 Cr for FY26; future expansion on 30-acre land acquisition in Bhiwadi for capacity growth.
Risks
Volume decline from 17.8 Cr to 17.5 Cr pairs; competitive intensity in mass segments.
Earnings Call filed with BSE, NSE: RELAXO. Summary written with AI assistance from the document.
Relaxo Footwears Ltd: key numbers
- Share price
- ₹289.00
- Market cap
- ₹7,194 Cr
- Revenue (annual)
- ₹2,702 Cr
- Net profit (annual)
- ₹179.3 Cr
- P/E (TTM)
- 38.8×Sector 66.8×
- Promoter holding
- 71.27%+0.00% QoQ
- FII holding
- 3.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Relaxo Footwears Ltd
All →Relaxo Footwears Annual General Meeting
Relaxo Footwears Limited held its 42nd Annual General Meeting on September 24, 2026. The meeting discussed financial statements, dividends, and director re-appointments.
Relaxo Footwears Other Announcement
Relaxo Footwears Limited has submitted its Business Responsibility and Sustainability Report for FY 2025-26. This report forms an integral part of its annual regulatory disclosures.
Relaxo Footwears Annual General Meeting
Relaxo Footwears Limited has issued a notice for its 42nd Annual General Meeting scheduled for September 24, 2026. Key agenda items include a 350% final dividend declaration.
Relaxo Footwears Annual Report
Relaxo Footwears published its Annual Report for FY 2025-26 and convened its 42nd AGM on September 24, 2026. The report highlights annual revenue of Rs. 2,702.16 Crore.
Relaxo Footwears Management Change
Relaxo Footwears Limited announced the re-appointment of several directors and key executives, alongside the appointment of Mr. Ashish Nigam as Head - Central Purchase.
Relaxo Footwears Employee Stock Options
Relaxo Footwears Limited has approved the grant of 5,03,500 employee stock options under its ESOP Plan-2014 to eligible employees.